Cite

    I. Castellví et al.. “AB0806 Rituximab in clinical practice for the treatment of interstitial lung disease refractory to cyclophosphamide in patients with diffuse systemic sclerosis.” Annals of the rheumatic diseases, vol. 71, n.d., p. 684. http://access.bl.uk/ark:/81055/vdc_100137792654.0x00005b